Table: Oncolys Biopharma -2022 parent results

Oncolys Biopharma

10/02/2023 06:00

Feb 10 (Reuters)- 
          Oncolys Biopharma Inc. 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Dec 31, 2022    Dec 31, 2021   Dec 31, 2023     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales          976 mln         642 mln                               
               (+51.9 pct)    (+104.5 pct)                             
  Operating     loss 1.20       loss 1.45                              
  Recurring     loss 1.16       loss 1.50                              
  Net           loss 1.15       loss 1.62                              
  EPS        loss 66.31 yen  loss 95.50 yen                            
  Ann Div          NIL             NIL            NIL                  
  -Q2 Div          NIL             NIL            NIL                  
  -Q4 Div          NIL             NIL            NIL                  
  
  NOTE - Oncolys Biopharma Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4588.T